Company Furiex Pharmaceuticals Inc
Equities
US36106P1012
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
2014 | Actavis : M&A frenzy in healthcare sector | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,816,005 | 7,922,310 ( 73.25 %) | 0 | 73.25 % |
Company contact information
Furiex Pharmaceuticals, Inc.
3900 Paramount Parkway Suite 150
27560, Morrisville
+(919) 456-7800
Sector
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- Stock
- Company Furiex Pharmaceuticals Inc